Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast CancerJessica J. Tao, Maurizio Scaltriti, Haley Ellis et al.|Science Signaling|2014Cited by 166